Allan Reine

Insider Reports History

Location
Boston, MA
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Allan Reine:

Company Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Financial Officer Common Stock 53,784 $443,718 $8.25 16 Jan 2024 Direct
Foghorn Therapeutics Inc. Chief Financial Officer Stock Option (right to buy) 90,000 $275,400 $3.06 16 Jan 2024 Direct
Prime Medicine, Inc. Chief Executive Officer, Director Common Stock 125,000 $147,150 $1.18 21 May 2025 Direct
Prime Medicine, Inc. Chief Executive Officer, Director Stock Option (right to buy) 1,300,000 26 Feb 2026 Direct

Insider Reports Filed by Allan Reine

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRME Prime Medicine, Inc. 26 Feb 2026 1 $0 4 Chief Executive Officer, Director 27 Feb 2026, 16:52
PRME Prime Medicine, Inc. 01 Aug 2025 2 $0 4 Chief Executive Officer, Director 05 Aug 2025, 20:42
PRME Prime Medicine, Inc. 21 May 2025 1 +$147,150 4 Chief Executive Officer, Director 22 May 2025, 16:18
PRME Prime Medicine, Inc. 19 May 2025 1 $0 4 Chief Executive Officer, Director 19 May 2025, 19:44
PRME Prime Medicine, Inc. 08 May 2025 1 $0 4 Chief Financial Officer 12 May 2025, 16:50
PRME Prime Medicine, Inc. 27 Feb 2025 1 $0 4 Chief Financial Officer 03 Mar 2025, 20:11
PRME Prime Medicine, Inc. 05 Dec 2024 1 $0 4 Chief Financial Officer 09 Dec 2024, 18:22
PRME Prime Medicine, Inc. 17 May 2024 1 $0 4 Chief Financial Officer 21 May 2024, 16:11
PRME Prime Medicine, Inc. 17 Jan 2024 1 $0 4 Chief Financial Officer 19 Jan 2024, 16:19
PRME Prime Medicine, Inc. 17 Jan 2024 0 $0 3 Chief Financial Officer 19 Jan 2024, 16:17
FHTX Foghorn Therapeutics Inc. 16 Jan 2024 0 $0 4 Chief Financial Officer 17 Jan 2024, 16:01
FHTX Foghorn Therapeutics Inc. 26 Jan 2023 1 $0 4 Chief Financial Officer 30 Jan 2023, 16:02
FHTX Foghorn Therapeutics Inc. 26 Jan 2022 1 $0 4 Chief Financial Officer 28 Jan 2022, 15:26
FHTX Foghorn Therapeutics Inc. 09 Aug 2021 2 +$100,038 4 Chief Financial Officer 11 Aug 2021, 16:14